首页> 外文OA文献 >Anti-interleukin-6 receptor antibody, tocilizumab, for the treatment of autoimmune diseases

【2h】

Anti-interleukin-6 receptor antibody, tocilizumab, for the treatment of autoimmune diseases

机译：抗白介素6受体抗体tocilizumab，用于治疗自身免疫性疾病

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Tanaka Toshio; Narazaki Masashi; Kishimoto Tadamitsu;
展开▼
作者单位

展开▼
年度 2011
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Anti-interleukin-6 receptor antibody, tocilizumab, for the treatment of autoimmune diseases [J] . TanakaT., NarazakiM., KishimotoT. FEBS letters. . 2011,第23期

机译：抗白介素6受体抗体tocilizumab，用于治疗自身免疫性疾病
2. Successful treatment of autoimmune hemolytic anemia associated with multicentric Castleman disease by anti-interleukin-6 receptor antibody (tocilizumab) therapy. [J] . Yuzuriha A, Saitoh T, Koiso H, Acta Haematologica . 2011,第3期

机译：通过抗白介素6受体抗体（tocilizumab）治疗成功治疗与多中心Castleman病相关的自身免疫性溶血性贫血。
3. Successful treatment of a patient with multicentric castleman's disease who presented with thrombocytopenia, ascites, renal failure and myelofibrosis using tocilizumab, an anti-interleukin-6 receptor antibody [J] . KawabataH., KotaniS.-I., MatsumuraY., Internal medicine. . 2013,第13期

机译：使用抗白介素6受体抗体tocilizumab成功治疗患有血小板减少症，腹水，肾功能衰竭和骨髓纤维化的多中心Castleman病患者
4. The interleukin-1 family cytokines and receptors in autoimmune and autoinflammatory diseases [C] . Lucchesi D., Anzilotti C., Del Corso I., European Congress of Immunology . 2009

机译：自身免疫和自身炎症疾病中白细胞介素-1家族细胞因子和受体
5. Regulation of autoimmune disease by chemokines and chemokine receptors. [D] . Fife, Brian Thomas. 2001

机译：趋化因子和趋化因子受体对自身免疫疾病的调节。
6. Autoimmunity: 346 Clinical Effects of Tocilizumab a Humanized Anti-interleukin-6 Receptor Antibody on Patients with Autoimmune and Allergic Diseases [O] . Toshio Tanaka, Atsuyoshi Morishima, Yoshihiro Hishitani, 2012

机译：自身免疫：346人源化抗白介素6受体抗体Tocilizumab对自身免疫和过敏性疾病患者的临床效果
7. Response to Treatment with an Anti-Interleukin-6 Receptor Antibody (Tocilizumab) in a Patient with Hemophagocytic Syndrome Secondary to Immune Checkpoint Inhibitors [O] . Alejandro Olivares-Hernández, Luis Figuero-Pérez, María A. Amores Martín, 2021

机译：抗白细胞介素-6受体抗体（对患者患者患有血糖综合征的患者的治疗响应于免疫检查点抑制剂

Anti-interleukin-6 receptor antibody, tocilizumab, for the treatment of autoimmune diseases

著录项

引文网络

相似文献

相关主题

期刊订阅